Citius Pharmaceuticals, Inc. (CTXR): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2017-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$9.98M
Year ended 2017-09-30
2015-09-30: -$3.23M2016-09-30: -$7.45M2017-09-30: -$9.98M-$9.98M
2015-09-30 EBITDA (USD) 2017-09-30
Period endedEBITDAChange YoYSource filing
2017-09-30-$9.98Mn/m2019-12-16, From 2016-10-01
2016-09-30-$7.45Mn/m2018-12-11, From 2015-10-01
2015-09-30-$3.23Mn/a2017-12-13, From 2014-10-01